United Orthopedic Corporation Stock

Equities

4129

TW0004129002

Medical Equipment, Supplies & Distribution

End-of-day quote Taipei Exchange 06:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
94.2 TWD +0.11% Intraday chart for United Orthopedic Corporation -1.57% +10.69%
Sales 2024 * 4.77B 147M Sales 2025 * - Capitalization 9.09B 279M
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 1.9 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * -
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees -
Yield 2024 *
5.31%
Yield 2025 *
-
Free-Float 89.41%
More Fundamentals * Assessed data
Dynamic Chart
United Orthopedic Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
United Orthopedic Corporation Appoints Cheng Chih Chieh as Chief Information Security Officer CI
United Orthopedic Corporation Announces Cash Dividend for the Year Ended December 31, 2023 CI
United Orthopedic Corporation Announces Dividend Distribution for the Year Ended December 31, 2023 CI
United Orthopedic Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
United Orthopedic Corporation(TPEX:4129) added to S&P Global BMI Index CI
United Orthopedic Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
United Orthopedic Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
United Orthopedic Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
United Orthopedic Corporation(TPEX:4129) dropped from S&P Global BMI Index CI
United Orthopedic Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
United Orthopedic Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
United Orthopedic Corporation Reports Earnings Results for the Full Year Ended December 31, 2021 CI
United Orthopedic Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
United Orthopedic Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
More news
1 day+0.11%
1 week-1.57%
Current month-4.56%
1 month-4.17%
3 months-8.99%
6 months+44.26%
Current year+10.69%
More quotes
1 week
91.00
Extreme 91
95.60
1 month
91.00
Extreme 91
101.00
Current year
82.80
Extreme 82.8
110.00
1 year
57.80
Extreme 57.8
110.00
3 years
27.50
Extreme 27.5
110.00
5 years
25.50
Extreme 25.5
110.00
10 years
25.50
Extreme 25.5
110.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 93-03-04
Director of Finance/CFO - 16-10-02
Chief Tech/Sci/R&D Officer - 16-06-30
Members of the board TitleAgeSince
Director/Board Member - 97-05-14
Chief Executive Officer - 93-03-04
Director/Board Member - 14-06-22
More insiders
Date Price Change Volume
24-04-25 94.2 +0.11% 245,270
24-04-24 94.1 +1.73% 316,921
24-04-23 92.5 -0.32% 441,208
24-04-22 92.8 -0.32% 400,785
24-04-19 93.1 -2.10% 1,136,861

End-of-day quote Taipei Exchange, April 24, 2024

More quotes
United Orthopedic Corporation is a Taiwan-based company principally engaged in the research, development, manufacture and distribution of joint prosthesis products. The Company’s main products consist of artificial hip joints, artificial knee joints, internal fixation of spines, orthopedic internal fixation of nails, bony plates, bony nails, osseous pins, bony screws and others. The Company distributes its products in Taiwan, the rest of Asia, the Americas, Europe and Africa markets.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
94.2 TWD
Average target price
126 TWD
Spread / Average Target
+33.76%
Consensus

Quarterly revenue - Rate of surprise